244 related articles for article (PubMed ID: 16838169)
21. CpG DNA induces stronger immune responses with less toxicity than other adjuvants.
Weeratna RD; McCluskie MJ; Xu Y; Davis HL
Vaccine; 2000 Mar; 18(17):1755-62. PubMed ID: 10699323
[TBL] [Abstract][Full Text] [Related]
22. Low-dose intraperitoneal Freund's adjuvant: toxicity and immunogenicity in mice using an immunogen targeting amyloid-beta peptide.
Oscherwitz J; Hankenson FC; Yu F; Cease KB
Vaccine; 2006 Apr; 24(15):3018-25. PubMed ID: 16307832
[TBL] [Abstract][Full Text] [Related]
23. Effect on cellular recruitment and the innate immune response by combining saponin, monophosphoryl lipid-A and Incomplete Freund's Adjuvant with Leishmania (Viannia) braziliensis antigens for a vaccine formulation.
Vitoriano-Souza J; Siqueira Mathias FA; Moreira NDD; Aguiar-Soares RDO; de Abreu Vieira PM; Teixeira-Carvalho A; Carneiro CM; Giunchetti RC; de Brito RCF; Fujiwara RT; Roatt BM; Melo MN; Reis AB
Vaccine; 2019 Nov; 37(49):7269-7279. PubMed ID: 31575491
[TBL] [Abstract][Full Text] [Related]
24. Immunomodulatory activity of disulphide bridged peptides related to lactoferrin immunosuppressive mini-domain.
Wieczorek Z; Słoń J; Siemion IZ
Pol J Pharmacol; 1995; 47(5):451-5. PubMed ID: 8868139
[TBL] [Abstract][Full Text] [Related]
25. The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells.
De Becker G; Moulin V; Pajak B; Bruck C; Francotte M; Thiriart C; Urbain J; Moser M
Int Immunol; 2000 Jun; 12(6):807-15. PubMed ID: 10837408
[TBL] [Abstract][Full Text] [Related]
26. CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice.
Maletto B; Rópolo A; Morón V; Pistoresi-Palencia MC
J Leukoc Biol; 2002 Sep; 72(3):447-54. PubMed ID: 12223511
[TBL] [Abstract][Full Text] [Related]
27. Immunological adjuvant effect of Boswellia serrata (BOS 2000) on specific antibody and cellular response to ovalbumin in mice.
Gupta A; Khajuria A; Singh J; Singh S; Suri KA; Qazi GN
Int Immunopharmacol; 2011 Aug; 11(8):968-75. PubMed ID: 21371582
[TBL] [Abstract][Full Text] [Related]
28. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.
Bomford R
Clin Exp Immunol; 1980 Feb; 39(2):435-41. PubMed ID: 6248283
[TBL] [Abstract][Full Text] [Related]
29. Effect of monophosphoryl lipid A on antibody response to diphtheria toxin and its subunits.
Caglar K; Aybay C; Ataoglu H
APMIS; 2005 Apr; 113(4):256-63. PubMed ID: 15865606
[TBL] [Abstract][Full Text] [Related]
30. Differential patterns of cyclosporine A-induced inhibition of humoral and cellular immune responses to sheep erythrocytes in mice.
Zimecki M; Wieczorek Z
Pol J Pharmacol; 2001; 53(5):495-500. PubMed ID: 11990068
[TBL] [Abstract][Full Text] [Related]
31. Platycodin D2 is a potential less hemolytic saponin adjuvant eliciting Th1 and Th2 immune responses.
Xie Y; Deng W; Sun H; Li D
Int Immunopharmacol; 2008 Aug; 8(8):1143-50. PubMed ID: 18550019
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus-like particles combined with novel adjuvant systems enhance virus-specific immune responses.
Qiao M; Murata K; Davis AR; Jeong SH; Liang TJ
Hepatology; 2003 Jan; 37(1):52-9. PubMed ID: 12500188
[TBL] [Abstract][Full Text] [Related]
33. A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens.
Swaminathan G; Thoryk EA; Cox KS; Meschino S; Dubey SA; Vora KA; Celano R; Gindy M; Casimiro DR; Bett AJ
Vaccine; 2016 Jan; 34(1):110-9. PubMed ID: 26555351
[TBL] [Abstract][Full Text] [Related]
34. Enhanced efficacy and immunogenicity of 78kDa antigen formulated in various adjuvants against murine visceral leishmaniasis.
Nagill R; Kaur S
Vaccine; 2010 May; 28(23):4002-12. PubMed ID: 20093205
[TBL] [Abstract][Full Text] [Related]
35. Prophylactic vaccination with adjuvant monophosphoryl lipid a prevents Th2-mediated murine asthmatic responses.
Wu CJ; Chou HW; Liou CJ; Shen JJ; Wang LC; Kuo ML
J Asthma; 2013 May; 50(4):327-33. PubMed ID: 23343407
[TBL] [Abstract][Full Text] [Related]
36. Immunoadjuvant activity of icariin that induces Th1-type antibody in mice.
Rhew KY; Han Y
Arch Pharm Res; 2012 Sep; 35(9):1685-91. PubMed ID: 23054726
[TBL] [Abstract][Full Text] [Related]
37. Immunoadjuvant activity in mice of polysaccharides isolated from the leaves of Panax ginseng C.A. Meyer.
Hwang SH; Shin MS; Yoon TJ; Shin KS
Int J Biol Macromol; 2018 Feb; 107(Pt B):2695-2700. PubMed ID: 29107141
[TBL] [Abstract][Full Text] [Related]
38. Anti-oxidants inhibit the enhancement of the immune response caused by oil adjuvants.
Di Gianni P; Minnucci FS; Alves Rosa MF; Vulcano M; Isturiz MA
Scand J Immunol; 1996 Apr; 43(4):413-20. PubMed ID: 8668921
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants.
Hernández A; Yager JA; Wilkie BN; Leslie KE; Mallard BA
Vet Immunol Immunopathol; 2005 Mar; 104(1-2):45-58. PubMed ID: 15661330
[TBL] [Abstract][Full Text] [Related]
40. Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.
Skrastina D; Petrovskis I; Lieknina I; Bogans J; Renhofa R; Ose V; Dishlers A; Dekhtyar Y; Pumpens P
PLoS One; 2014; 9(12):e114006. PubMed ID: 25436773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
